CD4 and acute myeloid leukemia: In this regard, loading moDC with both AML-lysate and mRNA was found superior to each method alone, possibly because the dual targeting of class I and class II presentation pathways allows the concomitant priming of CD4+ helper T cells that further promote CD8+ T cell responses [99].